Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEXAIS exenatide trial in acute ischaemic stroke
ACTRN12617000409370Phase 2Completed
- Sponsor
- Monash University
- Start
- Nov 2017
- Modality
- Peptides
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial in brain infarction comparing Exenatide with Standard of care (2 arms). Primary endpoint: Early neurological improvement. Started Nov 2017; status: completed.
02
Drugs
exenatide
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12617000409370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000409370.